Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Return on Assets (2016 - 2025)

Seres Therapeutics (MCRB) has disclosed Return on Assets for 11 consecutive years, with 0.91% as the latest value for Q2 2025.

  • Quarterly Return on Assets rose 99.0% to 0.91% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 0.91% through Jun 2025, up 99.0% year-over-year, with the annual reading at 0.51% for FY2024, 29.0% up from the prior year.
  • Return on Assets hit 0.91% in Q2 2025 for Seres Therapeutics, up from 0.88% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.91% in Q2 2025 to a low of 0.79% in Q3 2022.
  • Historically, Return on Assets has averaged 0.06% across 5 years, with a median of 0.14% in 2023.
  • Biggest five-year swings in Return on Assets: plummeted -69bps in 2022 and later surged 99bps in 2025.
  • Year by year, Return on Assets stood at 0.17% in 2021, then crashed by -222bps to 0.55% in 2022, then soared by 82bps to 0.1% in 2023, then soared by 880bps to 0.79% in 2024, then rose by 15bps to 0.91% in 2025.
  • Business Quant data shows Return on Assets for MCRB at 0.91% in Q2 2025, 0.88% in Q1 2025, and 0.79% in Q4 2024.